Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3155 (LINC03155) is a non-protein coding RNA molecule classified as a lincRNA, which are defined as long non-coding RNAs transcribed from intergenic regions of the genome that do not overlap with protein-coding genes. LincRNAs overall have been implicated in gene regulation, chromatin organization, and enhancer activity, with some members acting as regulators of cell identity and disease states; however, there is currently no reported biological function, clinical, or experimental relevance specific to LINC03155 in the biomedical literature. There is limited or no evidence in the current literature or genomic databases as of 2024 indicating that LINC03155 is a well-characterized or functionally validated target in biomedical research or as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3155 (LINC03155).